Sangamo’s gene therapy product candidate for Fabry disease shows continued tolerability and promise as an alternative to Enzyme Replacement Therapy
de
Cell Culture Dish Podcast
2023-02-02 16:32:49
Fecha de lanzamiento
18:15
Duración
